Unlocking CSU pathogenesis to shape the future treatment landscape

touchPANEL DISCUSSION for touchIMMUNOLOGY

Listen to a panel of experts discuss how emerging endotypes in chronic spontaneous urticaria are driving the development of much-needed new treatment and management approaches.

The experts:

• Prof. Dr med. Marcus Maurer – Charité University Medicine, Berlin, Germany
• Dr Melinda Gooderham – SKiN Centre for Dermatology, Ontario, Canada
• Prof. David Khan – Southwestern Medical Center, University of Texas, USA

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchimmunologyime.org/csu-pathogenesis-to-treatment/